The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...

Compounded Tirzepatide, Semaglutide, and Bioidentical HRT Telehealth Plans Through Gala GLP-1: Licensed Providers, $149/Mo ...

The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and providers are getting the dose wrong on compounded versions, and the ...

Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities. Reading time 3 minutes Trying to get a bargain ...

Compounded GLP-1 products remain widely available in weight-loss clinics and medical spas despite resolution of the previous product shortages, new research suggested. Widespread shortages of the ...

Semaglutide and tirzepatide telehealth access, compounded GLP-1 program pricing, refund terms, and weight loss medication ...

A recent op-ed in the Washington Post describes the story of an author who decided he wanted to lose weight. Although he was healthy, he heard from friends how easy and effective GLP-1 medications ...

As GLP-1 medications grow in popularity not just for treating diabetes but also for weight loss, some people are turning to alternatives that health experts warn may carry risks. Amelia Baker, a ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Novo Nordisk reported positive Phase 3 results for oral semaglutide in children and adolescents with type 2 diabetes, positioning it as a potential first oral GLP-1 option for this group. The company ...